Loss of Morrbid in Pstpip2−/− mice significantly inhibited the initiation and progression of CRMO symptoms and mitigated activation of myeloid cells and the excessive release of inflammatory cytokines. The gene discussed is MIR4435-2HG; the disease is chronic recurrent multifocal osteomyelitis.